COVAXIN | The Business Standard
Skip to main content
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • Epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা
The Business Standard
SUNDAY, APRIL 18, 2021
SUNDAY, APRIL 18, 2021
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • Epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা

COVAXIN

Addressing a petroleum university’s convocation, Modi said: “Work is being done to nearly double the country’s oil refining capacity in the next five years” Photo: Collected from Twitter
Coronavirus chronicle

Narendra Modi gets second dose of Covid vaccine

Modi took the first shot of the 'Made in India' Covaxin vaccine developed by Bharat Biotech on March 1

he Drug Controller General of India VG Somani said both firms submitted data on their trial runs Picture: Collected
Coronavirus chronicle

Covaxin can be taken off 'clinical trial mode', expert panel recommends

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

Bharat Biotech shot shows high immune response, further study needed for elderly

he Drug Controller General of India VG Somani said both firms submitted data on their trial runs Picture: Collected
Coronavirus chronicle

Covaxin safe, can be stored at 2-8°C, says Lancet report

he Drug Controller General of India VG Somani said both firms submitted data on their trial runs Picture: Collected
Coronavirus chronicle

Covaxin shows interim clinical efficacy of 81% in Phase 3 results

Modi's ministers choose 'Made in India' vaccine over AstraZeneca
Coronavirus chronicle

Modi's ministers choose 'Made in India' vaccine over AstraZeneca

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's Covid-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India's COVAXIN likely effective against UK variant - study

Reena Jani, 34, a health worker, receives the vaccine developed by Oxford/AstraZeneca at Mathalput Community Health Centre, during the coronavirus disease (Covid-19) pandemic, in Koraput, India, January 16, 2021. REUTERS/Danish Siddiqui
Coronavirus chronicle

From factory to faraway village: Behind India's mammoth vaccination drive

he Drug Controller General of India VG Somani said both firms submitted data on their trial runs Picture: Collected
Coronavirus chronicle

India to give homegrown vaccine in seven more states this week

Workers pack syringes at the Hindustan Syringes factory in Faridabad, India on Sept. 2, 2020. SAJJAD HUSSAIN/AFP/GETTY IMAGES
Analysis

India’s vaccine diplomacy

Representational image. Picture: Collected
Coronavirus chronicle

Bharat Biotech's Covid-19 shot safe, produced immune response in early human trial

he Drug Controller General of India VG Somani said both firms submitted data on their trial runs Picture: Collected
Coronavirus chronicle

Covaxin phase 1 trial clears Lancet review, phase 3 trial ongoing

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Covid-19 in Bangladesh

India's Bharat Biotech seeks Bangladesh trial for Covid vaccine approved at home

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]

Copyright © 2021 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab